^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Gastric Cancer |
| Drug: | paclitaxel (Bcl2 inhibitor, Tubulin polymerization promoter) + capecitabine (Thymidylate synthase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
12/23/2020
Excerpt:
Gastric Cancer: Perioperative chemoradiation...Preferred regimens…Fluoropyrimidine (fluorouracil or Capecitabine) and paclitaxel (Category 2B)
